Back to Top Skip to main content

Influenza, Northern Hemisphere

Frequently Asked Questions (FAQ) about 2020-21 influenza vaccine availability 

Visit the 2020-2021 Seasonal Influenza Resource Center

Flu disease picture  Influenza is a highly contagious viral infection. There are three main antigen types of influenza: types A, B, and C. Influenza type A causes moderate to severe illness and affects all age groups. Type A can infect both humans and animals. The notion that influenza type B generally causes milder disease than type A has been recently challenged and is more fatal in children. Type B mainly infects humans. Influenza type C only causes mild respiratory illness. Influenza activity peaks from December to March in the Northern Hemisphere.

Influenza is transmitted from person to person mainly when an infected person coughs or sneezes. Transmission can also occur from direct contact with respiratory secretions, such as when touching surfaces contaminated with influenza virus and then touching the eyes, nose, or mouth, or from indirect contact with droplets from coughs or sneezes. Transmission can occur from the day before symptoms begin until about 5 days after symptoms begin in adults, or up to 10 days or more after symptoms begin in children.

About 50% of infected persons will develop "classic" influenza disease. This is characterized by the abrupt onset of fever, muscle pain, sore throat, nonproductive cough, runny nose, and headache. These symptoms generally last from 2 to 3 days. However, some people may experience a loss of strength or energy for several weeks. In addition, some people may develop complications, such as pneumonia.

Source: Centers for Disease Control and Prevention

You also may be interested in...

Guidance for the 2018-2019 Annual Influenza Immunization Program

Policy

ASD(HA) memo detailing the forthcoming immunization requirements for the 2018-19 influenza season.

Immunization Recommendations for Disaster Response Operations

Fact Sheet
8/30/2017

This information paper provides immunization recommendations and resources for Department of Defense (DoD) personnel supporting disaster response operations, both in CONUS and OCONUS.

Recommended Content:

Vaccine-Preventable Diseases | Vaccine Recommendations by AOR | Humanitarian Assistance and Disaster Relief | Vaccine Schedules | Hepatitis A | Hepatitis B | Influenza, Northern Hemisphere | Tetanus-Diphtheria-Pertussis | Rabies

Community Mitigation Guidelines to Prevent Pandemic Influenza

Publication
4/21/2017

When a novel influenza A virus with pandemic potential emerges, nonpharmaceutical interventions (NPIs) often are the most readily available interventions to help slow transmission of the virus in communities, which is especially important before a pandemic vaccine becomes widely available.

Recommended Content:

Influenza, Northern Hemisphere

Department of Defense Guidance Regarding Thimerosal Containing Vaccines

Policy

This memo provides guidance regarding the use of vaccines containing Thimerosal.

<< < 1 2 > >> 
Showing results 16 - 19 Page 2 of 2

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.